Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Supreme Court to Hear Generic Drug Lawsuit Over Design Defects December 3, 2012 Irvin Jackson Add Your Comments The U.S. Supreme Court has decided to review a generic drug lawsuit, which deals with the question of whether manufacturers can be held liable for selling dangerous and defectively designed generic medications. On Friday, the nation’s highest court agreed to hear an appeal stemming from a personal injury and product liability lawsuit brought by Karen Bartlett, of New Hampshire, against Mutual Pharmaceutical co., a subsidiary of Takeda Pharmaceuticals. Bartlett alleges that she developed a severe skin reaction, known as Stevens-Johnson Syndrome (SJS), after taking a generic non-steroidal anti-inflammatory (NSAID) called sulindac. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As a result of the condition, Bartlett was hospitalized for 70 days, with 50 of those days were spent in a burn unit. She had multiple surgeries and two major septic shock episodes that were allegedly caused by side effects of the generic drug, which has left her with burns over 65 percent of her body and permanently blinded. Following trial in December 2004, Bartlett was awarded $21 million by a jury, which found that Mutual’s sulindac medication was responsible for the development of Steven’s-Johnson Syndrome. Mutual Pharmaceutical has maintained that it should not be liable for the allegedly defective design of the generic drug, arguing that they should be immune from liability, so long as the medication used the same warning label as the original brand-name version of the drug, which is marketed by Merck as Clinoril. The generic drug maker has argued that the controversial 2011 Supreme Court decision in Pliva v. Mensing establishes that the plaintiff’s design defect claims should have been pre-empted by federal regulations on generic drug makers. In Pliva v. Mensing, the Supreme Court ruled 5-4 down ideological lines that generic drug makers can not be held liable for failing to warn about risks associated with their medications, even if they knew or should have known that the warning label is inadequate. The majority of the Court determined that FDA regulations that require generic drug labels to match their brand-name equivalents made it impossible for generic drug makers to comply with both federal and state law. As a result of the Supreme Court decision, thousands of product liability lawsuits pending against the manufacturers of generic medications have been dismissed or at risk of being thrown out, including lawsuits over generic Reglan, Accutane, Darvocet, Zocor and others. On November 30, the U.S. Supreme Court court granted certification (PDF) of an appeal from the First Circuit to evaluated whether the lower court erred when it held that federal law does not pre-empt state law design defect claims involving generic drugs, as opposed to failure to warn claims addressed in Pliva. Plaintiffs have argued that the conflict between such claims and the federal laws governing generic drug design can be avoided if the manufacturers of the generic equivalents simply stop making their products. In attempt to further insulate themselves from liability lawsuits stemming from generic drugs they make, a number of generic drug manufacturers have filed briefs in the case. Tags: Drug Side Effects, Generic Drug, Stevens-Johnson Syndrome, Supreme Court, Toxic Epidermal Necrolysis More Lawsuit Stories Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 July 18, 2025 DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit July 18, 2025 Children Nicotine Pouch Ingestion Reports Have Increased by More Than 760%: Study July 18, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025) Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025) Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)
DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit July 18, 2025
Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025)
Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)
Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)